Results 151 to 160 of about 393,919 (333)

IgG4-related autoimmune disease : imaging findings [PDF]

open access: yes, 2013
IgG4 autoimmune disease (or hyper IgG4 disease) is a relatively recently described systemic disease that is characterised by abundant infiltration of IgG4-positive plasma cells and lymphocytes with associated fibrosis leading to organ dysfunction ...
Vassallo, Pierre
core  

Safety and Efficacy Findings From a Phase Ib/II Study of ASP‐1929 Photoimmunotherapy With Pembrolizumab in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma

open access: yesHead &Neck, Volume 48, Issue 1, Page 160-174, January 2026.
ABSTRACT Background ASP‐1929 photoimmunotherapy—cetuximab conjugated to IRDye 700DX and red light (690 nm) for localized drug activation—results in rapid, selective cell killing. Methods This phase Ib/II open‐label study evaluated ASP‐1929 photoimmunotherapy plus pembrolizumab in patients with recurrent/metastatic HNSCC (≥ 1 accessible lesion, PD‐L1 ...
David M. Cognetti   +17 more
wiley   +1 more source

Autoimmune and Neoplastic Thyroid Diseases Associated with Hepatitis C Chronic Infection

open access: yesInternational Journal of Endocrinology, 2014
Frequently, patients with hepatitis C virus (HCV) chronic infection have high levels of serum anti-thyroperoxidase and/or anti-thyroglobulin autoantibodies, ultrasonographic signs of chronic autoimmune thyroiditis, and subclinical hypothyroidism, in ...
Poupak Fallahi   +5 more
doaj   +1 more source

Predictive Factors of Response and Real‐World Experience of Baricitinib on Alopecia Areata: A Single Tertiary Center Study on a 72 Patients' Cohort

open access: yes
International Journal of Dermatology, EarlyView.
Alonso García‐Núñez   +6 more
wiley   +1 more source

Fuzuloparib with or without apatinib as maintenance therapy in newly diagnosed, advanced ovarian cancer (FZOCUS‐1): A multicenter, randomized, double‐blind, placebo‐controlled phase 3 trial

open access: yesCA: A Cancer Journal for Clinicians, Volume 76, Issue 1, January/February 2026.
Abstract Although poly(adenosine diphosphate‐ribose) polymerase inhibitors (PARPis) and bevacizumab were approved as first‐line maintenance for advanced ovarian cancer (OC), evidence comparing this combination with PARPi monotherapy, especially in BRCA‐mutated/homologous recombination‐deficient (HRD) patients, is lacking.
Lingying Wu   +56 more
wiley   +1 more source

SREAT presenting as decades of intractable seizures and isolated delusional episodes with clinical, laboratory, and EEG confirmation of treatment response

open access: yesSAGE Open Medical Case Reports, 2019
We report a case of a 60-year-old woman with a history of intractable seizures and isolated delusional psychosis who was later diagnosed with steroid-responsive encephalopathy associated with autoimmune thyroiditis.
Elysia Tjong   +2 more
doaj   +1 more source

Lymphocytic Thyroiditis and Diabetes in the BB/W Rat: A New Model of Autoimmune Endocrinopathy [PDF]

open access: bronze, 1981
Elliot Sternthal   +3 more
openalex   +1 more source

Autologous Hematopoietic Stem Cell Transplantation in Systemic Sclerosis: Current Evidence and Future Directions

open access: yesACR Open Rheumatology, Volume 7, Issue 12, December 2025.
Systemic sclerosis (SSc) is a rare autoimmune connective tissue disease marked by progressive fibrosis and multi‐organ involvement, most notably in the lungs. Among patients with rapidly progressive diffuse cutaneous SSc and interstitial lung disease (ILD), autologous hematopoietic stem cell transplantation (AHSCT) has emerged as one of the most ...
Cristiana Sieiro Santos
wiley   +1 more source

SALT score distribution with ritlecitinib treatment up to 24 months in alopecia areata

open access: yes
Journal of the European Academy of Dermatology and Venereology, EarlyView.
Ziad Reguiai   +8 more
wiley   +1 more source

Genotype–Phenotype Correlation in TTC7A ‐Associated Gastrointestinal Defects and Immunodeficiency Syndrome 1

open access: yesAmerican Journal of Medical Genetics Part A, Volume 197, Issue 12, December 2025.
ABSTRACT Gastrointestinal defects and immunodeficiency syndrome 1 (GIDID1) is a rare autosomal recessive disorder caused by biallelic variants in TTC7A. GIDID1 is characterized by a broad clinical spectrum ranging from very early‐onset inflammatory bowel disease (VEOIBD) to multiple intestinal atresia (MIA) with or without immunological manifestations.
Julia Imhoff   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy